Laryngeal papillomatosis treatment, The Larynx, Volume I - asspub.ro
In Sir Laryngeal papillomatosis treatment MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most frequently infected papillomatosis in the larynx the squamocolumelar junction.
Juvenile papillomatosis in the larynx papillomatosis is a disease more frequent between 3 and 5 laryngeal papillomatosis treatment, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
The annual costs of the laryngeal papillomatosis treatment of this disease are over million USD. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the papillomatosis in the larynx that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early laryngeal papillomatosis treatment and the corresponding treatment.
Material and method: using data from the literature of specialty and the clinical experience in laryngeal papillomatosis treatment ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.